# Repeated proliferative events ameliorate age-associated accumulation of DNA damage in HSPCs

**Authors:** Shubham Haribhau Mehatre, Harsh Agrawal, Irene Mariam Roy, Sarah Schouteden, Satish Khurana

PMC · DOI: 10.26508/lsa.202503337 · Life Science Alliance · 2026-01-29

## TL;DR

Frequent blood withdrawals in mice reduce DNA damage in hematopoietic stem cells as they age, without harming their function.

## Contribution

Repeated proliferative events in HSPCs ameliorate age-related DNA damage without affecting function.

## Key findings

- Serial blood withdrawals reduce age-associated DNA damage in HSPCs.
- Increased proliferation activates DNA damage response pathways in HSPCs.
- Proliferation in aged mice decreases double-strand breaks in HSPCs.

## Abstract

Repeated proliferative events during the lifetime reduce DNA damage accumulation in HSPCs over aging without impacting their function.

Upon aging, hematopoietic stem cells show accumulation of DNA damage that has been causally linked with their functional decline, with debatable role of proliferative events. In this study, we sought to enquire the effect of increased proliferation rate in hematopoietic stem and progenitor cells (HSPCs) on hematopoietic aging. Multiple rounds of blood withdrawals were performed during adult life to maintain a higher proliferation rate in HSPC population in mice. Our experiments showed little effect of increased proliferation on age-associated functional decline in the hematopoietic system. However, we noted a decrease in the double-strand breaks accumulated with age after the serial bleeding regimen. Analysis of scRNA-Seq data from mouse and human HSPCs showed enrichment of DNA damage response pathways. Importantly, we demonstrate that the induction of HSPC proliferation in aged mice was sufficient to activate the DNA damage response in vivo and decrease the load of double-strand breaks. Hence, these results show that repeated blood withdrawals equivalent to clinical blood donation clear DNA damages without impacting the functioning of HSPCs.

## Linked entities

- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Lig4 (ligase IV, DNA, ATP-dependent) [NCBI Gene 319583] {aka 5830471N16Rik, tiny}, Kit (Kit proto-oncogene receptor tyrosine kinase) [NCBI Gene 16590] {aka Bs, CD117, Fdc, Gsfsco1, Gsfsco5, Gsfsow3}, Palb2 (partner and localizer of BRCA2) [NCBI Gene 233826], Bmi1 (Bmi1 proto-oncogene, polycomb ring finger) [NCBI Gene 12151] {aka Bmi-1, Pcgf4}, Cd34 (CD34 antigen) [NCBI Gene 12490], Blm (Bloom syndrome, RecQ like helicase) [NCBI Gene 12144], Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Xrcc5 (X-ray repair complementing 5) [NCBI Gene 22596] {aka CTC85, CTCBF, Ku80, Ku86, Kup80}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Brca1 (breast cancer 1, early onset) [NCBI Gene 12189], Xrcc1 (X-ray repair complementing 1) [NCBI Gene 22594] {aka Xrcc-1}, Tdg (thymine DNA glycosylase) [NCBI Gene 21665] {aka E130317C12Rik, JZA-3, Jza1}, Cetn2 (centrin 2) [NCBI Gene 26370] {aka 1110034A02Rik, Calt, caltractin}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Flt3 (FMS-like tyrosine kinase 3) [NCBI Gene 14255] {aka B230315G04, CD135, Flk-2, Flk2, Flt-3, Ly72}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Rpa3 (replication protein A3) [NCBI Gene 68240] {aka 14kDa, C330026P08Rik}, Ddb1 (damage specific DNA binding protein 1) [NCBI Gene 13194] {aka 127kDa, p127-Ddb1}, Rfc4 (replication factor C (activator 1) 4) [NCBI Gene 106344] {aka A1, RFC37}, Neil1 (nei endonuclease VIII-like 1 (E. coli)) [NCBI Gene 72774] {aka 2810450N13Rik, NEH1, Nei1}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Cd48 (CD48 antigen) [NCBI Gene 12506] {aka BCM1, BLAST, BLAST-1, BLAST1, Bcm-1, MEM-102}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, Cdkn1b (cyclin dependent kinase inhibitor 1B) [NCBI Gene 12576] {aka Kip1, p27, p27Kip1}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Mpp2 (membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)) [NCBI Gene 50997] {aka D11Bwg0652e, Dlg2, Dlgh2, Pals4}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 18538], Mre11a (MRE11A homolog A, double strand break repair nuclease) [NCBI Gene 17535] {aka Mre11, Mre11b}, Procr (protein C receptor, endothelial) [NCBI Gene 19124] {aka Ccca, Ccd41, Epcr}, Slamf1 (signaling lymphocytic activation molecule family member 1) [NCBI Gene 27218] {aka 4933415F16, CD150, CDw150, ESTM51, IPO-3, Slam}, Atm (ataxia telangiectasia mutated) [NCBI Gene 11920] {aka C030026E19Rik}, Topbp1 (topoisomerase (DNA) II binding protein 1) [NCBI Gene 235559] {aka 1110031N14Rik, 2810429C13Rik, D430026L04Rik, mKIAA0259}, Neil3 (nei like 3 (E. coli)) [NCBI Gene 234258], Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Rfc5 (replication factor C (activator 1) 5) [NCBI Gene 72151] {aka 2610020K06Rik, 2610209F07Rik, 36.5kDa, 36kDa, Recc5}, Parp1 (poly (ADP-ribose) polymerase family, member 1) [NCBI Gene 11545] {aka 5830444G22Rik, ARTD1, Adprp, Adprt1, PARP, PPOL}
- **Diseases:** LSK (MESH:C565664), inflammatory (MESH:D007249), bone marrow (BM) failure (MESH:D000080983), dislocation (MESH:D004204), DNA (MESH:D004266), hematopoietic malignancies (MESH:D019337), bleeding (MESH:D006470), malformations (MESH:C564254), blood loss (MESH:D016063)
- **Chemicals:** ammonium acetate (MESH:C018824), NaCl (MESH:D012965), base (MESH:D009711), PBS (MESH:D007854), reactive oxygen species (MESH:D017382), acetic acid (MESH:D019342), FITC (MESH:D016650), ethanol (MESH:D000431), EDTA (MESH:D004492), DMSO (MESH:D004121), Triton X-100 (MESH:D017830), Baytril (MESH:D000077422), sodium acetate trihydrate (MESH:D019346), AF647 (MESH:C569686), PE (-), rapamycin (MESH:D020123), agarose (MESH:D012685), DAPI (MESH:C007293), TRIzol (MESH:C411644)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** LSKCD34- — Mus musculus (Mouse), Hybridoma (CVCL_J663), MPP3 — Homo sapiens (Human), Pleural epithelioid mesothelioma, Cancer cell line (CVCL_1427), LSK — Homo sapiens (Human), Ehlers-Danlos syndrome, Finite cell line (CVCL_U778)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12861689/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12861689/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12861689/full.md

---
Source: https://tomesphere.com/paper/PMC12861689